• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Astellas Pharma Inc

+ Add to Watchlist


14.4050 USD 0.1600 1.10%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Astellas Pharma Inc (ALPMY)

Open: 14.4800 Day's Range: 14.4000 - 14.4800 Volume: 1,011,490
Previous Close: 14.5650 52wk Range: 9.7440 - 14.6733 1-Yr Rtn: +44.95%

Stock Chart for ALPMY

No chart data available.
  • ALPMY:US 14.4050
  • 1D
  • 1M
  • 1Y
Interactive ALPMY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALPMY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 32,912.88
Shares Outstanding (M) 2,284.82
30 Day Average Volume 58,353
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.91%
Cash Dividend (USD) 0.1093
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 13.56%
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALPMY

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ALPMY

Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia

Masafumi NogimoriChairmanYoshihiko HatanakaPresident/CEO
Yoshiro MiyokawaExecutive Vice PresidentMasao YoshidaSenior Executive Officer
More Company Profile & Key Executives for ALPMY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil